Grovet is moving! Due to the relocating, we will be closed from May 29 to May 31 2024. No orders will be processed or shipped during this period. However, it is possible to place your order. More information about the relocating, you can find here. If you have any questions or concerns, please do not hestitate to contact us at info@grovet.com.

Difosfonal 300 mg 6 x 10 ml

Nr.
33090
Brand:
SPA - Società Prodotti Antibiotici
Batch:
2301
Expiry date:
31-Jul-2026
Registration number:
IT: A.I.C.: 026510038

Is the registration number of your country not listed? Then this product falls within the cascade control system.

Clodronic acid

Disclaimer: Product in the photo may differ from the actual product.

DIFOSFONAL 300 mg / 10 ml concentrate for solution for infusion

Therapeutic Indications:

  • Tumor Osteolysis.
  • Multiple myeloma.
  • Primary hyperparathyroidism.
  • Prevention and treatment of postmenopausal osteoporosis.

Pharmacotherapeutic group: Drugs affecting bone structure and mineralization.

Clodronate is mainly excreted by the kidneys. Therefore, during the treatment with clodronate it is necessary to ensure adequate moisture absorption.

Instructions for use

DIFOSFONAL 300 mg / 10 ml concentrate for solution for infusion contains 54 mg sodium per dose. This medicine is for intravenous use only.
This should be taken into account when administering to patients with reduced kidney function or on a controlled sodium diet.

Clodronate disodium (Clodronic acid disodium salt) - 300mg / 10ml concentration for infusion solution

 

Veterinary advice

DIFOSFONAL is not recommended during pregnancy.

© 2024 Grovet B.V. All rights reserved.